182 related articles for article (PubMed ID: 14660719)
21. A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET.
Green LA; Nguyen K; Berenji B; Iyer M; Bauer E; Barrio JR; Namavari M; Satyamurthy N; Gambhir SS
J Nucl Med; 2004 Sep; 45(9):1560-70. PubMed ID: 15347725
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG PET/CT-related metabolic parameters and their value in early prediction of chemotherapy response in a VX2 tumor model.
Song SL; Deng C; Wen LF; Liu JJ; Wang H; Feng D; Wong CY; Huang G
Nucl Med Biol; 2010 Apr; 37(3):327-33. PubMed ID: 20346872
[TBL] [Abstract][Full Text] [Related]
23. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
[TBL] [Abstract][Full Text] [Related]
24. Kinetic analysis of experimental rabbit tumour and inflammation model with 18F-FDG PET/CT.
Liu P; Huang G; Dong S; Wan L
Nuklearmedizin; 2009; 48(4):153-8. PubMed ID: 19384450
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis.
Kawai N; Nishiyama Y; Miyake K; Tamiya T; Nagao S
Ann Nucl Med; 2005 Dec; 19(8):685-90. PubMed ID: 16444994
[TBL] [Abstract][Full Text] [Related]
26. Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas.
Rusten E; Rødal J; Revheim ME; Skretting A; Bruland OS; Malinen E
Acta Oncol; 2013 Aug; 52(6):1160-7. PubMed ID: 23198721
[TBL] [Abstract][Full Text] [Related]
27. A method to quantify the uptake rate of 2-[18F]fluoro-2-deoxy-D-glucose in tissues.
Laffon E; Allard M; Marthan R; Ducassou D
Nucl Med Commun; 2004 Aug; 25(8):851-4. PubMed ID: 15266182
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy.
Tseng J; Dunnwald LK; Schubert EK; Link JM; Minoshima S; Muzi M; Mankoff DA
J Nucl Med; 2004 Nov; 45(11):1829-37. PubMed ID: 15534051
[TBL] [Abstract][Full Text] [Related]
29. Using SUV as a guide to 18F-FDG dose reduction.
Cheng DW; Ersahin D; Staib LH; Della Latta D; Giorgetti A; d'Errico F
J Nucl Med; 2014 Dec; 55(12):1998-2002. PubMed ID: 25453048
[TBL] [Abstract][Full Text] [Related]
30. Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography.
Chen S; Ho C; Feng D; Chi Z
IEEE Trans Med Imaging; 2004 Apr; 23(4):426-32. PubMed ID: 15084068
[TBL] [Abstract][Full Text] [Related]
31. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
Zhuang H; Pourdehnad M; Lambright ES; Yamamoto AJ; Lanuti M; Li P; Mozley PD; Rossman MD; Albelda SM; Alavi A
J Nucl Med; 2001 Sep; 42(9):1412-7. PubMed ID: 11535734
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional clinical PET in lung cancer: validation and practical strategies.
Calvo R; Martí-Climent JM; Richter JA; Peñuelas I; Crespo-Jara A; Villar LM; García-Velloso MJ
J Nucl Med; 2000 Mar; 41(3):439-48. PubMed ID: 10716316
[TBL] [Abstract][Full Text] [Related]
33. Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT.
Gheysens O; Postnov A; Deroose CM; Vandermeulen C; de Hoon J; Declercq R; Dennie J; Mixson L; De Lepeleire I; Van Laere K; Klimas M; Chakravarthy MV
J Nucl Med; 2015 Oct; 56(10):1520-6. PubMed ID: 26229142
[TBL] [Abstract][Full Text] [Related]
34. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Doot RK; Dunnwald LK; Schubert EK; Muzi M; Peterson LM; Kinahan PE; Kurland BF; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
[TBL] [Abstract][Full Text] [Related]
35. The effect of renal failure on 18F-FDG uptake: a theoretic assessment.
Laffon E; Cazeau AL; Monet A; de Clermont H; Fernandez P; Marthan R; Ducassou D
J Nucl Med Technol; 2008 Dec; 36(4):200-2. PubMed ID: 19008285
[TBL] [Abstract][Full Text] [Related]
36. [18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.
Buchmann I; Vogg AT; Glatting G; Schultheiss S; Möller P; Leithäuser F; Schulte M; Gfrörer W; Kotzerke J; Reske SN
Cancer Biother Radiopharm; 2003 Jun; 18(3):327-37. PubMed ID: 12954120
[TBL] [Abstract][Full Text] [Related]
37. Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors.
Strauss LG; Koczan D; Klippel S; Pan L; Cheng C; Willis S; Haberkorn U; Dimitrakopoulou-Strauss A
J Nucl Med; 2008 Aug; 49(8):1238-44. PubMed ID: 18632818
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive quantification of the differential portal and arterial contribution to the liver blood supply from PET measurements using the 11C-acetate kinetic model.
Chen S; Feng D
IEEE Trans Biomed Eng; 2004 Sep; 51(9):1579-85. PubMed ID: 15376506
[TBL] [Abstract][Full Text] [Related]
39. Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [
Liu G; Shi Y; Hou X; Yu H; Hu Y; Zhang Y; Shi H
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1371-1382. PubMed ID: 38078950
[TBL] [Abstract][Full Text] [Related]
40. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
